⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL59968 | 0.83 | — | — | |
| SCHEMBL5984875 | 0.82 | — | — | |
| SCHEMBL27991569 | 0.80 | — | — | |
| SCHEMBL5985940 | 0.79 | — | — | |
| SCHEMBL1402306 | 0.78 | — | — | |
| SCHEMBL386283 | 0.77 | — | — | |
| SCHEMBL10992971 | 0.76 | — | — | |
| SCHEMBL229845 | 0.76 | — | — | |
| SCHEMBL56883 | 0.75 | — | — | |
| SCHEMBL5985852 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3891162-B1 | NOVEL DERIVATIVES OF N-3\"-GUANIDINO-2,5-DIDEOXY-5-FLUORO-4,6-DISUBSTITUTED-STREPTAMINE AMINOGLYCOSIDE ANTIBIOTICS | AGILEBIOTICS B V (NL) | 2024-03-06 | — | — | EP | disclosed |
| US-20240016706-A1 | MATERIALS FOR OBTURATION | SONENDO, INC. | 2024-01-18 | — | — | US | disclosed |
| US-20240010627-A1 | NOVEL GUANIDINE DERIVATIVE AND METHOD FOR PRODUCING SAME | PEPTIDREAM INC. (JP) | 2024-01-11 | — | — | US | disclosed |
| EP-4276096-A1 | NOVEL GUANIDINE DERIVATIVE AND METHOD FOR PRODUCING SAME | PeptiDream Inc. (JP) | 2023-11-15 | — | — | EP | disclosed |
| EP-3098273-B1 | DISPERSION CONTAINING METAL OXIDE PARTICLES | NIPPON CATALYTIC CHEM IND (JP) | 2022-07-06 | — | — | EP | disclosed |
| WO-2022099258-A1 | MATERIALS FOR OBTURATION | SONENDO, INC. (US) | 2022-05-12 | — | — | WO | disclosed |
| US-20220127297-A1 | Novel Antibacterial 3\"-Derivatives Of 4,6-Disubstituted 2,5-Dideoxystreptamine Aminoglycoside Antibiotics | AGILEBIOTICS B.V. (NL) | 2022-04-28 | — | — | US | disclosed |
| EP-3891162-A1 | NOVEL ANTIBACTERIAL 3\"-DERIVATIVES OF 4,6-DISUBSTITUTED 2,5-DIDEOXYSTREPTAMINE AMINOGLYCOSIDE ANTIBIOTICS | AGILeBiotics B.V. (NL) | 2021-10-13 | — | — | EP | disclosed |
| CN-108289794-B | Dental adhesive | 可乐丽则武齿科株式会社 | 2021-10-01 | — | — | CN | disclosed |
| EP-3018125-B1 | NOVEL COMPOUND, ORGANIC CATION TRANSPORTER 3 DETECTION AGENT, AND ORGANIC CATION TRANSPORTER 3 ACTIVITY INHIBITOR | SHIN NIPPON BIOMEDICAL LABORATORIES LTD (JP) | 2020-08-05 | — | — | EP | disclosed |
| EP-1219631-A1 | ANTIANDROGEN AGENTS | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2002-07-03 | — | — | EP | disclosed |
| US-6410523-B1 | BONE DEFECTS | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2002-06-25 | — | — | US | disclosed |
| US-20020045772-A1 | Vitamin D derivative having substituent at 2beta-position | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2002-04-18 | — | — | US | disclosed |
| EP-1167366-A1 | AMINE DERIVATIVES | Sankyo Company, Limited (JP) | 2002-01-02 | — | — | EP | disclosed |
| EP-1167357-A1 | ALPHA-SUBSTITUTED CARBOXYLIC ACID DERIVATIVES | Sankyo Company, Limited (JP) | 2002-01-02 | — | — | EP | disclosed |
| EP-1070704-A1 | VITAMIN D DERIVATIVES SUBSTITUTED AT THE 2$g(b)-POSITION | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2001-01-24 | — | — | EP | disclosed |
| EP-0632036-B1 | Amide derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses | SANKYO CO (JP) | 2000-03-01 | — | — | EP | disclosed |
| US-5614550-A | ANTICHOLESTEROL AGENTS OR ARTERIOSCLEROSIS AGENTS FOR HUMANS | SANKYO COMPANY, LIMITED (JP) | 1997-03-25 | — | — | US | disclosed |
| US-5534529-A | Substituted aromatic amides and ureas derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses | SANKYO COMPANY, LIMITED (JP) | 1996-07-09 | — | — | US | disclosed |
| EP-0632036-A2 | Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses | SANKYO COMPANY LIMITED (JP) | 1995-01-04 | — | — | EP | disclosed |